Metastasectomy for oligometastatic bone disease of the appendicular skeleton: A concise review
Journal of Surgical Oncology · 2023-09 · 128 (3) · 438-444
DOI: 10.1002/jso.27403 ↗At a glance
Übersichtsarbeit in Journal of Surgical Oncology, published online on 2023-08-04. Written by Lisa A Kafchinski. Institution: Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Major MEDLINE topics: Kidney Neoplasms, Metastasectomy, Carcinoma, Renal Cell, Bone Diseases. Cited 6 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
As the life expectancy of patients with carcinomas improves, there is an associated increase in the risk of development of metastatic bone disease. Patients with solitary or oligometastatic bone disease of the appendicular skeleton may benefit from metastasectomy and reconstruction to improve overall survival. Specifically, patients with renal cell carcinoma and a solitary metastatic bone lesion will have long‐term survival benefit from metastasectomy and reconstruction. There remains controversy in the literature about metastasectomy for solitary metastatic bone disease in other common carcinomas, such as breast and thyroid.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Cite
APA
Kafchinski, L. A. (2023). Metastasectomy for oligometastatic bone disease of the appendicular skeleton: A concise review. Journal of Surgical Oncology, 128(3), 438-444. https://doi.org/10.1002/jso.27403
Vancouver
Kafchinski LA. Metastasectomy for oligometastatic bone disease of the appendicular skeleton: A concise review. Journal of Surgical Oncology. 2023;128(3):438-444. doi:10.1002/jso.27403
BibTeX
@article{Kafchinski2023,
author = {Kafchinski, Lisa A},
title = {Metastasectomy for oligometastatic bone disease of the appendicular skeleton: A concise review},
journal = {Journal of Surgical Oncology},
year = {2023},
volume = {128},
number = {3},
pages = {438--444},
doi = {10.1002/jso.27403}
}
EUVIMED